These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7345479)

  • 1. [The effect of six years lasting primary non pharmacological prevention of coronary heart disease on hypercholesterolemia in occupationally working men (author's transl)].
    Kocemba J; Kawecka-Jaszcz K; Magdoń M
    Przegl Lek; 1981; 38(12):857-60. PubMed ID: 7345479
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of six years lasting non pharmacological prevention of coronary heart disease on body weight in obese occupationally working men (author's transl)].
    Kawecka-Jaszcz K; Magdoń M; Kocemba J
    Przegl Lek; 1981; 38(12):851-5. PubMed ID: 7345478
    [No Abstract]   [Full Text] [Related]  

  • 3. [Realization of the project of metabolic out-patient care in men with hypercholesterolemia according to the program of primary prevention of coronary disease (author's transl)].
    Kocemba J; Kawecka-Jaszcz K; Magdoń M
    Przegl Lek; 1977; 34(8):661-4. PubMed ID: 928815
    [No Abstract]   [Full Text] [Related]  

  • 4. [The methodological principles of the active prevention conducted within the framework of "the Polish trial" of the primary prevention of I.H.D (author's transl)].
    Rywik S; Szostak W; Mikołajczyk W; Bién S; Korsak A; Charzewska J; Neklanda-Trepka A; Kulesza W; Sznajd J; Szybiński Z; Szczeklik A; Mellibruda L; Magdoń M; Koblik T; Pach J; Wasowicz B
    Przegl Lek; 1976; 33(6):568-75. PubMed ID: 959604
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prevalence of hypercholesterolemia in the male population covered by Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Rywik S; Szostak WB; Charzewska J; Sznajd J; Wasowicz B; Magdoń M; Nowacki G
    Przegl Lek; 1979; 36(10):737-41. PubMed ID: 515458
    [No Abstract]   [Full Text] [Related]  

  • 6. [The results of the second year realization of the health education programm devoted the prevention of the coronary disease (author's transl)].
    Sznajd J; Walas M; Młodkowska K; Magdoń M; Uracz R
    Przegl Lek; 1978; 35(4-5):490-3. PubMed ID: 694012
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and treatment of hypercholesterolemia for prevention of coronary heart disease.
    Wang YR; Alexander GC; Meltzer DO
    Manag Care Interface; 2006 Jan; 19(1):25-9. PubMed ID: 16453992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain.
    Rubió PP
    Public Health; 1997 Jan; 111(1):33-40. PubMed ID: 9033222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood pressure values in men included in prevention of coronary heart disease (author's transl)].
    Kawecka-Jaszczowa K; Szczeklik J; Mysik M; Miłkowski A
    Przegl Lek; 1976; 33(6):623-8. PubMed ID: 959615
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risk factors and primary prevention].
    Richard JL
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1559-60. PubMed ID: 8745988
    [No Abstract]   [Full Text] [Related]  

  • 13. [A characterization of the population included in the primary prevention of coronary heart disease programme (author's transl)].
    Sznajd J; Rywik S; Pach J; Magdon M; Janus T; Olszanecki S
    Przegl Lek; 1975; 32(6):519-24. PubMed ID: 1144819
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effectiveness of primary prevention of ischaemic heart disease (author's transl)].
    Reinis Z; Pokorný J; Bazika V; Gorican K; Tiserová J; Stuchlíková E; Horáková D; Hrabovský F; Havránek T
    Sb Lek; 1981 Oct; 83(10):266-76. PubMed ID: 7302516
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increasing physical fitness as part of primary prevention of ischaemic heart disease (author's transl)].
    Suntychová M; Veselá M; Boudík F; Jedlicka J; Adamírová J
    Cas Lek Cesk; 1977 Sep; 116(37):1154-7. PubMed ID: 922781
    [No Abstract]   [Full Text] [Related]  

  • 16. Education and the risk factors of ischaemic heart disease.
    Geizerová H; Widimský J; Pistulková H; Hejl Z; Rakická E; Petrzilková Z; Janouch J; Grafnetter D; Santrûcek M; Balcarová O
    Cor Vasa; 1980; 22(6):410-7. PubMed ID: 7471755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How sound are recommendations for lowering cholesterol for the primary prevention of coronary heart disease?
    Oliver MF
    Br J Clin Pract; 1993; 47(1):26-9. PubMed ID: 8461245
    [No Abstract]   [Full Text] [Related]  

  • 18. [Population included in the programme for prevention of coronary heart disease (author's transl)].
    Sznajd J; Rywik S; Kiec E; Magdoń M; Pach J; Kowal S; Olszanecki S; Ryskala Z
    Przegl Lek; 1976; 33(6):599-605. PubMed ID: 959611
    [No Abstract]   [Full Text] [Related]  

  • 19. [The coronary disease prevention program in the Warsaw factories (author's transl)].
    Rywik S; Charzewska J; Szostak WB; Wagrowska H; Chabros E; Napierała M; Przestalska-Malkin H; Sobotowska M
    Przegl Lek; 1981; 38(10):747-52. PubMed ID: 7330260
    [No Abstract]   [Full Text] [Related]  

  • 20. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.